This inventor holds 3 USPTO granted patents. Top assignee: Richter Gedeon Vegyeszeti Gyar Rt. Active years: 1979-1980.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1979-1980
Title: Piroska Bartok Nee Berencsy: Innovator in Pharmaceutical Chemistry
Introduction
Piroska Bartok Nee Berencsy is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications. With a total of 3 patents to her name, her work has garnered attention in the scientific community.
Latest Patents
Among her latest patents, Piroska has developed innovative compounds such as 2-amino-cyclopent-1-ene-1-thiocarboxylic acid-disulfides. These compounds are designed to treat conditions related to noradrenaline dysfunction. The new compounds exhibit dopamine-.beta.-hydroxylase inhibiting effects, making them valuable in therapeutic applications. The method of treating noradrenaline dysfunction involves administering an effective dose of these acid derivatives, showcasing her commitment to advancing medical science.
Career Highlights
Piroska is currently associated with Richter Gedeon Vegyeszeti Gyar Rt, a prominent pharmaceutical company in Hungary. Her work at this institution has allowed her to focus on innovative research and development in the pharmaceutical sector. Her contributions have not only advanced her career but have also positively impacted the field of medicine.
Collaborations
Throughout her career, Piroska has collaborated with esteemed colleagues such as Gyorgy Matolcsy and Eva Palosi. These collaborations have fostered a productive environment for innovation and have led to the successful development of her patented compounds.
Conclusion
Piroska Bartok Nee Berencsy stands out as a significant figure in pharmaceutical innovation. Her dedication to research and development continues to influence the field, and her patents reflect her commitment to improving therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
